echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Nutrition News > UCLA study finds about 30% of COVID patients develop 'LONG COVID'

    UCLA study finds about 30% of COVID patients develop 'LONG COVID'

    • Last Update: 2022-05-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Image: COVID-19

    Credit: Pixabay

    Find

    New research from UCLA found that 30 percent of people treated for COVID-19 developed acute post-COVID-19 sequelae (PASC), the most common being the "long coronavirus


    Among the 309 patients in the study with prolonged COVID-19 infection, the most persistent symptoms were fatigue and shortness of breath in hospitalized patients (31% and 15%, respectively), and loss of smell in outpatient patients (16%)


    background


    Throughout the pandemic, the incidence and risk factors for the long coronavirus, and even how the syndrome is defined, remain unclear


    method


    UCLA researchers studied 1,038 patients who presented to the UCLA COVID-19 outpatient clinic between April 2020 and February 2021


    Potential weaknesses of the study include: the subjective nature of patient-assessed symptoms, the limited number of symptoms assessed by researchers, and limited information about patients' prior conditions


    Influence


    "This study demonstrates the need to follow different patient groups longitudinally to understand the trajectories of COVID-19 over time, and to assess individual factors such as pre-existing comorbidities, sociodemographic factors, vaccination status and types of viral variants, How it affects the type and persistence of COVID-19 symptoms over prolonged periods of time,



    author

    Additional authors of the study are Dr.




    Magazine

    journal of general internal medicine

    DOI

    10.


    method research

    observational study

    research topic

    people

    article title

    Factors associated with acute sequelae of SARS-CoV-2 (PASC) following inpatient and outpatient diagnosis of symptomatic COVID-19 in different cohorts

    Article publication date

    7 - April - 2022

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.